Your browser doesn't support javascript.
Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease.
González-Castro, A; Cuenca Fito, E; Fernandez, A; Escudero Acha, P; Rodríguez Borregán, J C; Peñasco, Y.
  • González-Castro A; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain. Electronic address: e409@humv.es.
  • Cuenca Fito E; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Fernandez A; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Escudero Acha P; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Rodríguez Borregán JC; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Peñasco Y; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Med Intensiva (Engl Ed) ; 46(5): 285-287, 2022 05.
Article in English | MEDLINE | ID: covidwho-1859974
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Case report Limits: Humans Language: English Journal: Med Intensiva (Engl Ed) Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Case report Limits: Humans Language: English Journal: Med Intensiva (Engl Ed) Year: 2022 Document Type: Article